Reading a certificate of analysis: where it helps and where the gap remains

A Certificate of Analysis (CoA) is a laboratory's documented test report that records the analytical measurements and test methods for a submitted material sample. This documented laboratory part is generally solid, because a testing laboratory analyzes exactly the sample it received by mail or submission. I have started my own project on the trustworthiness and quality of the laboratories themselves.

The critical safety gap lies between the tested laboratory sample and the specific vial in your hand, because no independent authority confirms the identity of both samples. Whether the seller actually submitted a sample from the goods delivered to you is something no one checks and cannot be verified afterwards. This guide explains which details you can reliably take from a certificate, which questions remain fundamentally open, and how to properly evaluate peptide test results.

Why doesn't the batch number help on the gray market?

On the gray market, a batch number does not provide proof of origin, because unlike in the regulated pharmaceutical market, it is neither independently controlled nor tamper-proof linked to the specific production run. In the regulated pharmaceutical world, the labeling on the certificate and the vial must match exactly, whereas this cross-check does not apply on the gray market for three practical reasons.

Often there are no real batches at all. Many labels do not refer to an actual production batch, but merely to a cap color, a month, a year, or the laboratory's internal reference number. A large portion of certificates in circulation lack a batch number entirely.

An existing number cannot be verified. No one independently checks whether the number on the label is authentic or was printed to match the certificate. A label remains a freely designable sticker.

The sample's origin remains unclear. Even with a formally matching number, it remains uncertain whether the tested vial comes from the same production run as your product. A supplier can have flawless material tested once and then sell different goods under the same name.

The practical consequence follows: insisting on a batch number does not filter out unreliable suppliers, but rather disadvantages those who transparently state the status of their goods. On the gray market, a batch number serves purely as an organizational aid, not as proof of origin.

What information can be read from a certificate?

The usefulness of a certificate of analysis depends on four key pieces of information in the testing section: laboratory, test method, specification, and date. If any of these four core parameters is missing, the document makes no reliable or verifiable statement about the tested material.

The laboratory. Is the testing laboratory named and publicly findable? Some laboratories offer a direct online query through which the original report can be viewed using an identifier. Such a database query is more tamper-proof than a static PDF that can be edited in minutes; a report created by the seller himself remains a mere self-declaration.

The test method. Every measurement result requires a defined analytical procedure. A percentage value without naming the method used is analytically unverifiable and carries no meaning.

The specification. In addition to the specific measured value, the defined acceptable range must be stated. A mere note like "conforms" without a numerical value and without a tolerance range is an unverified claim.

The date. When exactly did the measurement take place? A test date that precedes the stated manufacturing date is a contradiction; a date far in the past provides no information about the current state of the substance.

What does the purity value in the certificate of analysis mean?

The purity value of a peptide quantifies the signal ratio of the target peptide to the total area of all measured peaks in high-performance liquid chromatography (HPLC) with UV detection. In this optical separation method, the dissolved components pass by a detection window, each generating a signal (peak), and together they produce the percentage purity figure.

Purity therefore describes an optical area fraction in the chromatogram, not an absolute mass fraction in the powder. The value answers only what proportion of the substances detected by the detector was the target peptide, not how many milligrams of peptide are actually in the vial.

HPLC with UV detection also only captures substances that absorb light at the set wavelength. Systematically invisible are: residual solvents from manufacturing, inorganic impurities and heavy metals, bacterial toxins (endotoxins), as well as bound water and residual salts. Each of these substance groups requires its own analytical method; if a corresponding test point is missing from the certificate, it was not tested for.

Informative certificates state the net peptide content in addition to purity. This value quantifies the actual active ingredient fraction in the powder minus water and salts, whereby the purity value and net peptide content can differ by double-digit percentage points.

A high purity value is today's production standard in the market and hardly serves as a quality differentiator anymore. Anyone comparing suppliers primarily by the purity figure is relying on the least differentiating measurement.

What tests exist and what does each show?

The identity test answers whether the declared active ingredient is actually present by measuring the exact molecular mass and comparing it with the theoretical value. Without proof of identity, a purity figure only demonstrates that an unspecified substance is present in high concentration.

The purity test uses HPLC to determine how high the proportion of peptide-related by-products and impurities is relative to the main substance.

The content determination quantifies the absolute amount of active ingredient in the present powder using specific methods such as amino acid analysis.

The test for bacterial toxins uses the LAL test to check whether the material is contaminated with fever-inducing endotoxins. This test is the only one of the four parameters that provides a direct statement about microbiological safety for injection and is the most frequently missing on gray market certificates.

What can a certificate of analysis fundamentally not prove?

That your specific vial comes from the tested material. This gap in origin cannot be closed through the document, because the laboratory only tests the individual sample presented to it.

That the goods were properly transported and stored after analysis. A certificate documents only the state at the time of the laboratory measurement and makes no statements about subsequent storage conditions.

That the active ingredient content is still unchanged today. Peptides undergo natural degradation, which is accelerated by heat exposure and storage time.

What can you rely on for quality assessment instead?

For reliable quality assessment, the methodological proximity of the test report to the specific vial serves as the most important benchmark, since the gap in origin with a dealer certificate fundamentally remains. This results in a clear three-tier ranking of evidence according to its reliability.

Strongest: your own laboratory test. An analysis you commission yourself of your individual vial is the only way without a gap in origin that turns assumptions into a measurable fact. The peptidetesting.cc project compiles reference points on costs and laboratories. You can find a starting point for trustworthy laboratories in your region on my project peptidetesting.cc.

Next: independent community tests by other buyers. Independent test reports on different orders of the same batch provide more reliable insights than a manufacturer's certificate, because the samples were not hand-picked by the seller. Buyers organize into test groups for this purpose to share laboratory costs and test results.

Next: the submitted dealer certificate. This document proves the analysis of a specific sample by a laboratory, but does not guarantee its correspondence with the goods delivered to you.

An additional quality criterion beyond the paper is the supplier's open handling of independent tests. Dealers who tolerate third-party blind tests, support test groups, and also publicly leave below-average analysis results up often offer a more reliable indicator on the gray market than mere PDF certificates.

From here on, it gets technical

For the basic evaluation of a certificate, the aforementioned criteria suffice; those who wish to deepen their understanding of the underlying pharmaceutical standards will find the regulatory framework in international guidelines.

For impurities in active ingredients, the ICH guidelines define binding thresholds: with a daily dose below 2 grams, the reporting threshold is 0.05 percent and the identification threshold is 0.10 percent. Residual solvents are divided into toxicological classes, of which highly toxic solvents are completely prohibited in manufacturing. For synthetic peptides, the guidelines of the European and American authorities (EMA/FDA) for generic peptides require that each individual peptide-related impurity amounts to a maximum of 0.50 percent of the active ingredient, with the entire impurity profile being assessed; for the formal structure of certificates of analysis, the World Health Organization (WHO) provides an internationally standardized template.

These pharmaceutical guidelines are binding for approved medicines; on the unregulated gray market, however, they serve exclusively as an analytical benchmark. They define what criteria a complete test report would have to meet, but they do not oblige gray market manufacturers to comply and do not bridge the missing chain of custody between the testing laboratory and the end product.